Skip to main content
Skip to main menu

Slideshow

Cell-Derived Nanoparticles as Cancer Vaccines

Portrait of Jianwen Li, graduate student speaker
Jianwen Li
Graduate Student, Department of Chemistry
University of Georgia
Chemistry Building, Room 400
Materials Chemistry and Nanoscience Seminar

Immune system protects our body from attacks by pathogens. Immune system can also accurately identify self and mutated peptides on cancer cells and amount an antitumor immune response.1 As a novel cancer treatment modality, cancer immunotherapy aims at training immune cells for antigen recognition or boosting antitumor immune response. Unlike conventional therapies, immunotherapy promises to eliminate both primary and distant tumors while establishing a long-term immune memory that prevents tumor recurrence. 2

Cancer vaccines are an emerging immunotherapeutic approach that works by stimulating antigen-specific immunological responses. One of the challenges has been the delivery of tumor antigens to antigen presenting cells (APCs). With appropriate sizes and high loading capacity, nanoparticles have been extensively investigated as delivery system for tumor antigens. 3 In this presentation, I will be talking about cancer cell derived nanovaccines, including those made from cell lysates, exosomes, or extracted cell membranes.4 Compared with the conventional approaches, cell derived nanovaccines feature prolonged circulation and unique physiochemical properties that benefit antigen processing, cross-presentation, and APC activation. 5

References

  1. De Visser, K. E., Eichten, A., & Coussens, L. M. (2006). Paradoxical roles of the immune system during cancer development. Nature reviews cancer6(1), 24-37.
  2. Pulendran, B., & Ahmed, R. (2011). Immunological mechanisms of vaccination. Nature immunology12(6), 509-517.
  3. Qin, M., Du, G., & Sun, X. (2020). Biomimetic cell-derived nanocarriers for modulating immune responses. Biomaterials Science8(2), 530-543.
  4. Meng, Z., Zhang, Y., Zhou, X., Ji, J., & Liu, Z. (2022). Nanovaccines with cell-derived components for cancer immunotherapy. Advanced drug delivery reviews, 114107.
  5. Raza, F., Zafar, H., Zhang, S., Kamal, Z., Su, J., Yuan, W. E., & Mingfeng, Q. (2021). Recent Advances in Cell MembraneDerived Biomimetic Nanotechnology for Cancer Immunotherapy. Advanced Healthcare Materials10(6), 2002081.

Support Us

We appreciate your financial support. Your gift is important to us and helps support critical opportunities for students and faculty alike, including lectures, travel support, and any number of educational events that augment the classroom experience. Click here to learn more about giving.

Every dollar given has a direct impact upon our students and faculty.

Got More Questions?

Undergraduate inquiries: chemreg@uga.edu 

Registration and credit transferschemreg@uga.edu

AP Credit, Section Changes, Overrides, Prerequisiteschemreg@uga.edu

Graduate inquiries: tharrop@uga.edu

Contact Us!

Assistant to the Department Head: Donna Spotts, 706-542-1919 

Main office phone: 706-542-1919 

Fax: 706-542-9454

Head of the Department: Prof. Gary Douberly